EARS News and Press, Auris Medical Holding AG From 05/25/21

Meeting essential requirements for marketing Bentrio TM in Europe under CE mark On track for first product launch in Europe towards end of Q2 2021 Hamilton, Bermuda, May 25, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to develo...

Auris Medical Holding (EARS) has reached the midpoint for enrollment in Part B of its Phase 2 proof-of-concept trial of AM-125 (intranasal betahistine) in the treatment of acute peripheral vertigo. In Part B of the TRAVERS trial, the Company will enroll 72 patients. The improvement in the &#x...

Hamilton, Bermuda, May 14, 2021 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today announced that it has reached the midpo...

Second Sight Medical Products (EYES) +24% on reporting two-year results of its Orion study.Upstart Holdings (UPST) +23% on Q1 results.Minerva Neurosciences (NERV) +23% on Q1 results.fuboTV Inc. (FUBO) +21% on Q1 results.Biomerica (BMRA) +17%.Lucira Health (LHDX) +16% ...

Auris Medical (EARS) climbed ~16.6% on Friday in apparent reaction to updates from a pollen challenge trial for its drug-free nasal spray, Bentrio.The open-label randomized cross-over trial in 36 patients has met the primary efficacy endpoint in allergic rhinitis after a s...

Are These Meme Penny Stocks On Your Under $5 List? We’ve all heard the terms, Reddit penny stocks, meme stocks , and any other popular trends that have come up this year. And if you’re new to penny stocks, these are some of the biggest trends in the market right now. ...

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Auris Medical Provides Update on Bentrio Program in Allergy” Auris Medical Holding Ltd. (NASDAQ: EARS) , a clinical-stage company dedicated to developing therape...

Gainers: Regional Health Properties (RHE) +39%, Auris Medical (EARS) +26%, Clene (CLNN) +25%, Pro-Dex (PDEX) +20%, Epizyme (EPZM) +17%.Losers: ChemoCentryx (CCXI) -59%, Orphazyme (ORPH) -30%, F-star Therapeutics (FSTX) -21%, Aur...

Bentrio TM meets primary efficacy endpoint in clinical evaluation in allergic rhinitis Clinically relevant and significant reduction in nasal symptoms Superior efficacy ratings by patients and clinicians Pre-submission meeting with FDA supports 510(k) regulatory pathway ...

Alterity Therapeutics (ATHE) +22%.Welbilt (WBT) +19% on being acquired by The Middleby Corp.Sierra Metals (SMTS) +12%.Williams Industrial Services (WLMS) +12%.Uxin Limited (UXIN) +9%.inTEST Corporation (INTT) +8%.Ocugen (OCGN) +7%.Energy Recover (ERII) +7%.Cerecor (CERC) +6%.Aesthetic Me...